Welcome!

News Feed Item

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

NEW YORK, Aug. 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

http://www.reportlinker.com/p02312122/Digital-Pathology-Market-by-Slide-Scanners-Whole-Slide-Imaging-Analytics-Image-Analysis-Software-Delivery-Modes-Web-Based/Cloud-Based--by-Whole-Slide-Image-Storage---Global-Forecasts--Trends-to-2018.html

The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018.

In 2013, the North American market was valued at $128.9 million and accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The North American market is expected to grow at a healthy growth rate over the next five years. This high growth can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, lack of FDA approvals for digital pathology to be used for primary diagnosis acts as a major barrier for the North American market.

The European region has gained momentum for digital pathology. Some of the European countries have witnessed successful pathology projects which are likely to lead to higher adoption of digital pathology in these countries. Furthermore, Europe hosts various digital pathology conferences that aim to bring professionals under one roof and bring to light the ongoing developments in digital pathology. However, the Asian market, slated at an estimated CAGR of 13.7%, will experience the highest growth in the digital pathology market. The rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the use of digital pathology to improve the quality of cancer diagnosis are some of the factors driving the growth of the Asian market.


The major players in this market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 REPORT DESCRIPTION 19
1.3 MARKETS COVERED 20
1.4 STAKEHOLDERS 22
1.5 RESEARCH METHODOLOGY 23
1.5.1 SECONDARY RESEARCH 23
1.5.2 PRIMARY RESEARCH 25
1.5.3 KEY DATA FROM PRIMARY SOURCES 26
1.5.4 MARKET FORECAST 29
1.5.5 MARKET DATA VALIDATION AND DATA TRIANGULATION 31
1.6 ASSUMPTIONS 32
2 EXECUTIVE SUMMARY 33
3 MARKET OVERVIEW 37
3.1 MARKET DYNAMICS 37
3.1.1 DRIVERS 38
3.1.1.1 Rising prevalence of cancer 38
3.1.1.2 Improvement in lab efficiency 38
3.1.1.3 Drug development 38
3.1.1.4 Increasing use of companion diagnostics 39
3.1.1.5 Ease of consultation enabled by digital pathology 39
3.1.2 RESTRAINTS 40
3.1.2.1 High cost of digital pathology systems 40
3.1.2.2 Regulatory concerns 40
3.1.2.3 Conservative outlook of pathologists 40

3.1.3 OPPORTUNITIES 41
3.1.3.1 Digital pathology to help combat the shortage of pathologists 41
3.1.3.2 Affordable scanners for private pathology practices 41
3.1.3.3 Biopharmaceutical and drug toxicology studies 42
3.1.3.4 Personalized medicine 42
3.1.3.5 Digital pathology to aid collaborations between Asia and the west 42
3.2 MARKET SHARE ANALYSIS 43
3.2.1 DIGITAL PATHOLOGY MARKET, BY KEY PLAYER 43
3.3 INDUSTRY SPEAKS 47
4 DIGITAL PATHOLOGY: RATIONALE FOR ADOPTION 49
4.1 INTRODUCTION 50
4.2 SIGNIFICANCE OF DIGITAL PATHOLOGY 51
4.2.1 GEOGRAPHIC DISTRIBUTION OF PATHOLOGISTS 51
4.2.2 CASE TRANSPORT 51
4.2.3 CASE REVIEW 51
4.2.4 ADDITIONAL STUDIES 52
4.2.5 DIAGNOSIS ENTRY 52
4.2.6 QUALITY CONTROL 52
4.3 WHY A LAB SHOULD ADOPT THE DIGITAL PATHOLOGY TECHNOLOGY 53
5 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT 59
5.1 INTRODUCTION 60
5.2 SCANNERS 62
5.3 ANALYTICS 64
5.3.1 VISUALIZATION SOFTWARE 64
5.3.2 DIGITAL PATHOLOGY INFORMATION MANAGEMENT SYSTEMS 64
5.3.3 IMAGE ANALYSIS PLATFORMS 64
5.4 STORAGE 66
5.5 COMMUNICATION/DELIVERY MODES 68
5.5.1 WEB-BASED 71
5.5.2 CLOUD-BASED 72
6 GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION 75
6.1 INTRODUCTION 76
6.2 HUMAN PATHOLOGY 78
6.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 80
6.2.2 HOSPITALS/REFERENCE LABORATORIES/ACADEMIC MEDICAL CENTERS (AMC) 81
6.2.3 TRAINING AND EDUCATION 83
6.3 ANIMAL PATHOLOGY 84
6.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 86
6.3.2 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 87
6.3.3 CONTRACT RESEARCH ORGANIZATIONS 89
7 GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY 91
7.1 INTRODUCTION 92
7.2 NORTH AMERICA 94
7.2.1 U.S. 97
7.2.1.1 Favorable reimbursement scenario for digital pathology in the U.S. to boost the market 97
7.2.2 CANADA 99
7.2.2.1 Embracing digital pathology to improve the quality of healthcare in Canada 99
7.3 EUROPE 102
7.3.1 U.K. 106
7.3.1.1 Technological developments in the U.K. to propel the market 106
7.3.1.2 Conferences in the U.K. to boost the market 106
7.3.2 GERMANY 108
7.3.2.1 Conferences in Germany to trigger growth 108
7.3.3 ITALY 110
7.3.3.1 Successful digital pathology projects in Italy 110
7.3.4 FRANCE 112
7.3.4.1 Use of digital pathology in the pharmaceutical industry to boost the market in France 112

7.3.5 SPAIN 114
7.3.5.1 Adoption of digital pathology to improve quality of healthcare 114
7.3.6 DENMARK 116
7.3.6.1 Alarming rise in prevalence of cancer to boost the market in Denmark 116
7.3.7 NORWAY 118
7.3.7.1 Digital pathology revolution in Norway to propel market growth 118
7.3.8 SWEDEN 120
7.3.8.1 Conferences in Sweden to boost the market 120
7.3.8.2 Positive funding scenario in Sweden to focus on innovation 121
7.3.9 REST OF EUROPE (ROE) 122
7.3.9.1 Digital pathology gaining momentum in the Netherlands 122
7.4 ASIA 125
7.4.1 CHINA 128
7.4.1.1 Collaborations in China to boost market growth 128
7.4.1.2 Ministry of Health in China encourages use of digital pathology 128
7.4.2 JAPAN 130
7.4.2.1 Focus on stomach cancer diagnosis to propel the market in Japan 130
7.4.3 INDIA 132
7.4.3.1 Digital pathology gaining momentum in India 132
7.4.4 MIDDLE EAST 134
7.4.4.1 Exhibitions in the Middle East to increase awareness of digital pathology 134
7.4.5 REST OF ASIA (ROA) 136
7.4.5.1 Bilateral agreements aimed to increase awareness of digital pathology in Pakistan 136
7.5 REST OF THE WORLD (ROW) 139
7.5.1 LATIN AMERICA 142
7.5.1.1 Players eyeing Brazil as an attractive market 142

7.5.2 AFRICA 144
7.5.2.1 Strategies by key players to aid growth of digital pathology in Africa 144
7.5.3 RUSSIA 146
7.5.3.1 Increasing popularity of digital pathology as a cost-effective solution to help propel the market in Russia 146
7.5.4 PACIFIC COUNTRIES 148
7.5.4.1 Patients in Pacific countries to receive better and timely diagnosis due to digital pathology 148
8 COMPETITIVE LANDSCAPE 151
8.1 INTRODUCTION 151
8.2 NEW PRODUCT LAUNCHES 155
8.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 156
8.4 ACQUISITIONS 158
8.5 OTHER DEVELOPMENTS 159
9 COMPANY PROFILES 161
(Overview, Financials, Products & Services, Strategy, & Developments)*

9.1 3DHISTECH LTD. 161
9.2 APOLLO PACS, INC. 166
9.3 AURORA INTERACTIVE LTD. 171
9.4 CORISTA LLC 174
9.5 DEFINIENS AG 177
9.6 DIGIPATH INC. 182
9.7 HAMAMATSU PHOTONICS K.K. 186
9.8 HURON TECHNOLOGIES INTERNATIONAL, INC. 191
9.9 INDICA LABS, INC. 195
9.10 KANTERON SYSTEMS 199
9.11 LEICA BIOSYSTEMS, GMBH 202
9.12 LIGOLAB, LLC 208
9.13 MIKROSCAN TECHNOLOGIES, INC. 210
9.14 NIKON INSTRUMENTS, INC. 213
9.15 OBJECTIVE PATHOLOGY SERVICES, LTD. 216
9.16 OMNYX, LLC 218
9.17 XIFIN, INC. 222
9.18 PATHXL, LTD. 225
9.19 PIXCELLDATA, LTD. 231
9.20 SUNQUEST INFORMATION SYSTEMS, INC. 234
9.21 VENTANA MEDICAL SYSTEMS, INC. 238
9.22 VISIOPHARM 246

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 TYPICAL LABORATORY WORKFLOW STEPS WITH INTEGRATED DIGITAL IMAGING 55
TABLE 2 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 61
TABLE 3 DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY REGION,
2011–2018 ($MILLION) 63
TABLE 4 DIGITAL PATHOLOGY MARKET FOR ANALYTICS, BY REGION,
2011–2018 ($MILLION) 65
TABLE 5 DIGITAL PATHOLOGY MARKET FOR STORAGE, BY REGION,
2011–2018 ($MILLION) 67
TABLE 6 DIGITAL PATHOLOGY MARKET FOR COMMUNICATION/DELIVERY MODES, BY REGION, 2011–2018 ($MILLION) 69
TABLE 7 GLOBAL DIGITAL PATHOLOGY MARKET FOR COMMUNICATION/ DELIVERY MODE, BY TYPE, 2011–2018 ($MILLION) 70
TABLE 8 DIGITAL PATHOLOGY MARKET FOR WEB-BASED COMMUNICATION,
BY REGION, 2011–2018 ($MILLION) 72
TABLE 9 DIGITAL PATHOLOGY MARKET FOR CLOUD-BASED COMMUNICATION, BY REGION, 2011–2018 ($MILLION) 74
TABLE 10 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 77
TABLE 11 GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 78
TABLE 12 HUMAN PATHOLOGY MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 79
TABLE 13 HUMAN PATHOLOGY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2011–2018 ($MILLION) 81
TABLE 14 HUMAN PATHOLOGY MARKET FOR HOSPITALS/REFERENCE LABORATORIES/ACADEMIC MEDICAL CENTERS (AMC), BY REGION, 2011–2018 ($MILLION) 82
TABLE 15 HUMAN PATHOLOGY MARKET FOR TRAINING AND EDUCATION,
BY REGION, 2011–2018 ($MILLION) 83
TABLE 16 GLOBAL ANIMAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 85
TABLE 17 ANIMAL PATHOLOGY MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 86
TABLE 18 ANIMAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2011–2018 ($MILLION) 87
TABLE 19 ANIMAL PATHOLOGY MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2011–2018 ($MILLION) 88
TABLE 20 ANIMAL PATHOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2011–2018 ($MILLION) 90
TABLE 21 DIGITAL PATHOLOGY MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 93
TABLE 22 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 94
TABLE 23 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 95
TABLE 24 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE,
BY COUNTRY, 2011–2018 ($MILLION) 96
TABLE 25 U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 98
TABLE 26 U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 99
TABLE 27 CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 100
TABLE 28 CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 101
TABLE 29 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 103
TABLE 30 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 104
TABLE 31 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY,
2011–2018 ($MILLION) 105
TABLE 32 U.K.: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 107
TABLE 33 U.K.: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 108
TABLE 34 GERMANY: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 109
TABLE 35 GERMANY: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 110
TABLE 36 ITALY: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 111
TABLE 37 ITALY: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 112
TABLE 38 FRANCE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 113
TABLE 39 FRANCE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 114
TABLE 40 SPAIN: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 115
TABLE 41 SPAIN: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 116
TABLE 42 DENMARK: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 117
TABLE 43 DENMARK: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 118
TABLE 44 NORWAY: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 119
TABLE 45 NORWAY: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 120
TABLE 46 SWEDEN: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 121
TABLE 47 SWEDEN: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 122
TABLE 48 ROE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 123
TABLE 49 ROE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 124
TABLE 50 ASIA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 125
TABLE 51 ASIA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 126
TABLE 52 ASIA: DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY,
2011–2018 ($MILLION) 127
TABLE 53 CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 129
TABLE 54 CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 130
TABLE 55 JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 131
TABLE 56 JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 132
TABLE 57 INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 133
TABLE 58 INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 134
TABLE 59 MIDDLE EAST: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 135
TABLE 60 MIDDLE EAST: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2011 – 2018 ($MILLION) 136
TABLE 61 ROA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 137
TABLE 62 ROA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 138
TABLE 63 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 139
TABLE 64 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 140
TABLE 65 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 141
TABLE 66 LATIN AMERICA: DIGITAL PATHOLOGY MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 142
TABLE 67 LATIN AMERICA: DIGITAL PATHOLOGY MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 143
TABLE 68 AFRICA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 145
TABLE 69 AFRICA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 146
TABLE 70 RUSSIA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2011–2018 ($MILLION) 147
TABLE 71 RUSSIA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
2011–2018 ($MILLION) 148
TABLE 72 PACIFIC COUNTRIES: DIGITAL PATHOLOGY MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 149
TABLE 73 PACIFIC COUNTRIES: DIGITAL PATHOLOGY MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 150
TABLE 74 NEW PRODUCT LAUNCHES, 2011–2014 155
TABLE 75 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2011–2014 156
TABLE 76 ACQUISITIONS, 2011–2014 158
TABLE 77 OTHER DEVELOPMENTS, 2011–2014 159
LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 23
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 25
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY 27
FIGURE 4 MARKET SIZING ($VALUE ANALYSIS) 28
FIGURE 5 COMPETITIVE ASSESSMENT (MARKET SHARE/STRATEGY ASSESSMENT FOR DIGITAL PATHOLOGY) 29
FIGURE 6 MARKET FORECASTING MODEL 30
FIGURE 7 DATA TRIANGULATION METHODOLOGY 31
FIGURE 8 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2013 VS. 2018 ($MILLION) 33
FIGURE 9 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GEOGRAPHY,
2013 VS. 2018 ($MILLION) 34
FIGURE 10 MARKET DYNAMICS 37
FIGURE 11 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 44
FIGURE 12 LABORATORY WORKFLOW WITH INTEGRATED DIGITAL IMAGING 54
FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT 60
FIGURE 14 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR SCANNERS,
2013 VS. 2018 (UNITS) 62
FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION 76
FIGURE 16 DIGITAL PATHOLOGY MARKET, GEOGRAPHICAL RANKING, 2013 92
FIGURE 17 KEY GROWTH STRATEGIES, 2011–2014 151
FIGURE 18 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCHES, 2011–2014 152
FIGURE 19 KEY PLAYERS FOCUSING ON AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2011–2014 153


FIGURE 1 RESEARCH METHODOLOGY 23
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 25
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY 27
FIGURE 4 MARKET SIZING ($VALUE ANALYSIS) 28
FIGURE 5 COMPETITIVE ASSESSMENT (MARKET SHARE/STRATEGY ASSESSMENT FOR DIGITAL PATHOLOGY) 29
FIGURE 6 MARKET FORECASTING MODEL 30
FIGURE 7 DATA TRIANGULATION METHODOLOGY 31
FIGURE 8 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
2013 VS. 2018 ($MILLION) 33
FIGURE 9 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GEOGRAPHY,
2013 VS. 2018 ($MILLION) 34
FIGURE 10 MARKET DYNAMICS 37
FIGURE 11 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 44
FIGURE 12 LABORATORY WORKFLOW WITH INTEGRATED DIGITAL IMAGING 54
FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT 60
FIGURE 14 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR SCANNERS,
2013 VS. 2018 (UNITS) 62
FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION 76
FIGURE 16 DIGITAL PATHOLOGY MARKET, GEOGRAPHICAL RANKING, 2013 92
FIGURE 17 KEY GROWTH STRATEGIES, 2011–2014 151
FIGURE 18 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCHES, 2011–2014 152
FIGURE 19 KEY PLAYERS FOCUSING ON AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2011–2014 153


To order this report: Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018
http://www.reportlinker.com/p02312122/Digital-Pathology-Market-by-Slide-Scanners-Whole-Slide-Imaging-Analytics-Image-Analysis-Software-Delivery-Modes-Web-Based/Cloud-Based--by-Whole-Slide-Image-Storage---Global-Forecasts--Trends-to-2018.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
As more and more companies are making the shift from on-premises to public cloud, the standard approach to DevOps is evolving. From encryption, compliance and regulations like GDPR, security in the cloud has become a hot topic. Many DevOps-focused companies have hired dedicated staff to fulfill these requirements, often creating further siloes, complexity and cost. This session aims to highlight existing DevOps cultural approaches, tooling and how security can be wrapped in every facet of the bu...
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
Docker containers have brought great opportunities to shorten the deployment process through continuous integration and the delivery of applications and microservices. This applies equally to enterprise data centers as well as the cloud. In his session at 20th Cloud Expo, Jari Kolehmainen, founder and CTO of Kontena, discussed solutions and benefits of a deeply integrated deployment pipeline using technologies such as container management platforms, Docker containers, and the drone.io Cl tool. H...
In his session at @ThingsExpo, Dr. Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, presented the findings of a series of six detailed case studies of how large corporations are implementing IoT. The session explored how IoT has improved their economic performance, had major impacts on business models and resulted in impressive ROIs. The companies covered span manufacturing and services firms. He also explored servicification, how manufacturing firms shift from se...
Connecting to major cloud service providers is becoming central to doing business. But your cloud provider’s performance is only as good as your connectivity solution. Massive Networks will place you in the driver's seat by exposing how you can extend your LAN from any location to include any cloud platform through an advanced high-performance connection that is secure and dedicated to your business-critical data. In his session at 21st Cloud Expo, Paul Mako, CEO & CIO of Massive Networks, wil...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, will provide a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to ...
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
SYS-CON Events announced today that CAST Software will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CAST was founded more than 25 years ago to make the invisible visible. Built around the idea that even the best analytics on the market still leave blind spots for technical teams looking to deliver better software and prevent outages, CAST provides the software intelligence that matter ...